Skip to content

QuidelOrtho Corporation QDEL Royalty and License Expenses

Royalty and License Expenses at other companies

HTF
Heartflow, Inc. Common StockHTFL
$568K+37.2%
HTF
Heartflow, Inc. Common StockHTFL
$568K+37.2%
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$85.5K+23.5%
Universal Display logo
Universal DisplayOLED
$104K-8.8%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$11.85M+47.2%
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$85.5K+23.5%

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$921.94M-51.4%
Enterprise value$3.88B-20.1%
P/S0.4×-0.3×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept qdel:RoyaltyAndLicenseExpenses.

The official record: QuidelOrtho Corporation’s 10-K, filed February 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's royalty and license expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's royalty and license expenses?
QuidelOrtho Corporation (QDEL) reported royalty and license expenses of $3.5M in Q4 2025.
How has QuidelOrtho Corporation's royalty and license expenses changed year-over-year?
QuidelOrtho Corporation's royalty and license expenses decreased by 24.3% year-over-year, from $4.63M to $3.5M.
What is the long-term trend for QuidelOrtho Corporation's royalty and license expenses?
Over 2 years (2023 to 2025), QuidelOrtho Corporation's royalty and license expenses has grown at a -19.9% compound annual growth rate (CAGR), from $21.8M to $14M.
What does royalty and license expenses mean?
Costs incurred for the use of intellectual property, patents, or proprietary technologies owned by third parties. These expenses reflect the company's reliance on external innovation and the ongoing operational costs required to maintain access to critical diagnostic or manufacturing technologies.